Bruce Edmund Snyder, MD | |
1800 W Charleston Blvd, Las Vegas, NV 89102-2329 | |
(702) 453-3799 | |
(702) 453-5741 |
Full Name | Bruce Edmund Snyder |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 1800 W Charleston Blvd, Las Vegas, Nevada |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306860770 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 11814 (Nevada) | Primary |
Entity Name | Pokroy Medical Group Of Nevada Ltd |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992809412 PECOS PAC ID: 7911037643 Enrollment ID: O20100607000694 |
News Archive
A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells.
ID Biomedical Corporation announced today that it has signed long term marketing, distribution and minimum purchase agreements with three of the largest influenza vaccine wholesalers in the United States: Henry Schein, Inc.; AmerisourceBergen Corporation's Specialty Group; and McKesson Corporation.
The percentage of U.S. female physician authors of original research in major gastroenterology journals has grown over time, yet the percentage of women in the senior author position remains lower than expected based on the proportion of female gastroenterologists in academia.
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Tarsa Therapeutics, Inc. today announced progress in the ORACAL trial of its oral calcitonin product for the treatment of postmenopausal osteoporosis. The company has completed patient enrollment in this multinational, randomized, double-blind, placebo-controlled Phase III trial designed to enroll approximately 550 patients. In addition, Tarsa announced that the independent Data Monitoring Committee (DMC) for the ORACAL trial has completed two separate safety reviews of patient data and recommended that the trial proceed as planned.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Bruce Edmund Snyder, MD 2290 Driftwood Tide Ave, Henderson, NV 89052-5803 Ph: (702) 485-2020 | Bruce Edmund Snyder, MD 1800 W Charleston Blvd, Las Vegas, NV 89102-2329 Ph: (702) 453-3799 |
News Archive
A new discovery from the University of Virginia School of Medicine has revealed an unknown clockwork mechanism within the body that controls the creation of oxygen-carrying red blood cells.
ID Biomedical Corporation announced today that it has signed long term marketing, distribution and minimum purchase agreements with three of the largest influenza vaccine wholesalers in the United States: Henry Schein, Inc.; AmerisourceBergen Corporation's Specialty Group; and McKesson Corporation.
The percentage of U.S. female physician authors of original research in major gastroenterology journals has grown over time, yet the percentage of women in the senior author position remains lower than expected based on the proportion of female gastroenterologists in academia.
For 80 years it has been accepted that early life began in a 'primordial soup' of organic molecules before evolving out of the oceans millions of years later. Today the 'soup' theory has been over turned in a pioneering paper in BioEssays which claims it was the Earth's chemical energy, from hydrothermal vents on the ocean floor, which kick-started early life.
Tarsa Therapeutics, Inc. today announced progress in the ORACAL trial of its oral calcitonin product for the treatment of postmenopausal osteoporosis. The company has completed patient enrollment in this multinational, randomized, double-blind, placebo-controlled Phase III trial designed to enroll approximately 550 patients. In addition, Tarsa announced that the independent Data Monitoring Committee (DMC) for the ORACAL trial has completed two separate safety reviews of patient data and recommended that the trial proceed as planned.
› Verified 1 days ago
Dr. Jason Craig Wickens, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 653 N Town Center Dr Ste 518, Las Vegas, NV 89144 Phone: 702-369-0200 Fax: 702-243-8383 | |
Dr. Surjeet Singh, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 401, Las Vegas, NV 89106 Phone: 702-896-6043 Fax: 702-896-9591 | |
Peter Lloyd Hildebrand, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5005 | |
Dr. Brett D Brimhall, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6850 N Durango Dr, 110, Las Vegas, NV 89149 Phone: 702-263-2020 Fax: 702-396-0287 | |
Helga F Pizio, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2020 Wellness Way Ste 402, Las Vegas, NV 89106 Phone: 702-485-5000 Fax: 702-485-5001 | |
Grace S Shin, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 6028 S Fort Apache Rd Ste 101, Las Vegas, NV 89148 Phone: 702-896-2020 Fax: 702-896-2025 | |
Dr. Jeffrey L. Hart, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 5871 W. Craig Rd., Las Vegas, NV 89130 Phone: 702-724-2020 Fax: 702-724-2800 |